
FAMILIAL NON-AUTOIMMUNE HYPERTHYROIDISM
IN FAMILY MEMBERS ACROSS FOUR GENERATIONS
DUE TO A NOVEL DISEASE-CAUSING VARIANT IN
THE THYROTROPIN RECEPTOR GENE Malej A, Avbelj Stefanija M, Bratanič N, Trebušak Podkrajšek K, *Corresponding Author: Associate Professor Katarina Trebušak Podkrajšek, Ph.D., Institute of Biochemistry
and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Slovenia. Tel: +386-
1-543-7669. Fax: +386-1-543-7641. E-mail: katarina.trebusakpodkrajsek@mf.uni-lj.si page: 87
|
INTRODUCTION
Thyrotropin receptor (TSHR) is a G-protein coupled
receptor that activates pathways enabling synthesis of the
thyroid hormones, and proliferation of the thyrocytes [1].
Activating disease-causing variants in the thyrotropinreceptor
(TSHR) gene are associated with non-autoimmune
hyperthyroidism. In familial non-autoimmune hyperthyroidism
(FNAH) activating variants are inherited in an autosomal
dominant manner [2], while in sporadic congenital
non-autoimmune hyperthyroidism (CNAH) they appear
de novo [3]. Familial non-autoimmune hyperthyroidism
is a rare disorder with 41 families reported so far in the
TSHR gene mutation database [4]. The onset of the disease
and clinical manifestations vary even between family
members with the same disease-causing variant and might
be influenced by the iodine intake and additional genetic
factors [5]. Familial non-autoimmune hyperthyroidism is
characterized by the positive family history of the nonautoimmune
hyperthyroidism with autosomal dominant
inheritance and can have variable onset and symptoms.
Patients develop goiter, while clinical and laboratory signs
of autoimmunity are not present [6]. Typically, patients
with FNAH experience recurrence after withdrawal of
the anti-thyroid treatment, non-ablative radioactive iodine
(I-131) treatment, or partial thyroidectomy [7]. In addition
to FNAH and CNAH, activating TSHR variants are associated
with hot thyroid nodules as reviewed in recent report
by Führer [8]. We present the clinical and genetic features
of patients with FNAH across four generations of a Slovenian
family due to a novel TSHR disease-causing variant.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|